209 related articles for article (PubMed ID: 30776968)
1. British Menopause Society consensus statement on the management of estrogen deficiency symptoms, arthralgia and menopause diagnosis in women treated for early breast cancer.
Marsden J; Marsh M; Rigg A;
Post Reprod Health; 2019 Mar; 25(1):21-32. PubMed ID: 30776968
[TBL] [Abstract][Full Text] [Related]
2. The British menopause society consensus statement on the management of estrogen deficiency symptoms, arthralgia and menopause diagnosis in women with treated for early breast cancer.
Marsden J
Post Reprod Health; 2022 Dec; 28(4):199-210. PubMed ID: 36050892
[TBL] [Abstract][Full Text] [Related]
3. Association of single nucleotide polymorphisms of cytochrome P450 enzymes with experience of vasomotor, vaginal and musculoskeletal symptoms among breast cancer patients: a systematic review.
Chan CWH; Law BMH; Ng MSN; Wong CCY; Wong CWY; Quinley M; Orgusyan JM; Chow KM; Waye MMY
BMC Cancer; 2021 May; 21(1):570. PubMed ID: 34006247
[TBL] [Abstract][Full Text] [Related]
4. Should urogenital atrophy in breast cancer survivors be treated with topical estrogens?
Trinkaus M; Chin S; Wolfman W; Simmons C; Clemons M
Oncologist; 2008 Mar; 13(3):222-31. PubMed ID: 18378532
[TBL] [Abstract][Full Text] [Related]
5. Vaginal atrophy in breast cancer survivors: role of vaginal estrogen therapy.
Mariani L; Gadducci A; Vizza E; Tomao S; Vici P
Gynecol Endocrinol; 2013 Jan; 29(1):25-9. PubMed ID: 22994445
[TBL] [Abstract][Full Text] [Related]
6. Overview of long term care of breast cancer survivors.
Brennan ME; Houssami N
Maturitas; 2011 Jun; 69(2):106-12. PubMed ID: 21489727
[TBL] [Abstract][Full Text] [Related]
7. The management of menopausal sequelae in patients with breast cancer.
Rostom AY
Clin Oncol (R Coll Radiol); 2001; 13(3):174-80. PubMed ID: 11527291
[TBL] [Abstract][Full Text] [Related]
8. Urogenital disorders in women with adjuvant endocrine therapy after early breast cancer.
Baumgart J; Nilsson K; Stavreus-Evers A; Kask K; Villman K; Lindman H; Kallak T; Sundström-Poromaa I
Am J Obstet Gynecol; 2011 Jan; 204(1):26.e1-7. PubMed ID: 20950790
[TBL] [Abstract][Full Text] [Related]
9. [Vaginal oestrogen therapy in women with hormone-sensitive breast cancer].
Bak AM; Laursen BE; Rungby J; Brock B
Ugeskr Laeger; 2011 Feb; 173(9):648-51. PubMed ID: 21362392
[TBL] [Abstract][Full Text] [Related]
10. [Aromatase inhibitors and arthralgia].
Nagykálnai T; Landherr L; Mészáros E
Magy Onkol; 2011 Mar; 55(1):32-9. PubMed ID: 21617789
[TBL] [Abstract][Full Text] [Related]
11. [Management of side effects related to adjuvant hormone therapy in young women with breast cancer].
Saghatchian M; Lesur A
Bull Cancer; 2019 Dec; 106(12S1):S37-S42. PubMed ID: 32008736
[TBL] [Abstract][Full Text] [Related]
12. Aromatase inhibitor-associated arthralgia syndrome.
Burstein HJ
Breast; 2007 Jun; 16(3):223-34. PubMed ID: 17368903
[TBL] [Abstract][Full Text] [Related]
13. Effectively nursing patients receiving aromatase inhibitor therapy.
Wengström Y
Breast; 2008 Jun; 17(3):227-38. PubMed ID: 18077168
[TBL] [Abstract][Full Text] [Related]
14. Arthralgia induced by endocrine treatment for breast cancer: A prospective study of serum levels of insulin like growth factor-I, its binding protein and oestrogens.
Lintermans A; Vanderschueren D; Verhaeghe J; Van Asten K; Jans I; Van Herck E; Laenen A; Paridaens R; Billen J; Pauwels S; Vermeersch P; Wildiers H; Christiaens MR; Neven P
Eur J Cancer; 2014 Nov; 50(17):2925-31. PubMed ID: 25304297
[TBL] [Abstract][Full Text] [Related]
15. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health.
Faubion SS; Larkin LC; Stuenkel CA; Bachmann GA; Chism LA; Kagan R; Kaunitz AM; Krychman ML; Parish SJ; Partridge AH; Pinkerton JV; Rowen TS; Shapiro M; Simon JA; Goldfarb SB; Kingsberg SA
Menopause; 2018 Jun; 25(6):596-608. PubMed ID: 29762200
[TBL] [Abstract][Full Text] [Related]
16. Consensus statement - Urogenital atrophy.
Briggs P
Post Reprod Health; 2022 Mar; 28(1):47-50. PubMed ID: 35103527
[TBL] [Abstract][Full Text] [Related]
17. Vaginal Atrophy in Breast Cancer Survivors: Attitude and Approaches Among Oncologists.
Biglia N; Bounous VE; D'Alonzo M; Ottino L; Tuninetti V; Robba E; Perrone T
Clin Breast Cancer; 2017 Dec; 17(8):611-617. PubMed ID: 28655486
[TBL] [Abstract][Full Text] [Related]
18. Update on management of genitourinary syndrome of menopause: A practical guide.
Palacios S; Castelo-Branco C; Currie H; Mijatovic V; Nappi RE; Simon J; Rees M
Maturitas; 2015 Nov; 82(3):308-13. PubMed ID: 26261035
[TBL] [Abstract][Full Text] [Related]
19. Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial.
Cuzick J; Sestak I; Cella D; Fallowfield L;
Lancet Oncol; 2008 Dec; 9(12):1143-8. PubMed ID: 18976959
[TBL] [Abstract][Full Text] [Related]
20. Side effects of aromatase inhibitors versus tamoxifen: the patients' perspective.
Garreau JR; Delamelena T; Walts D; Karamlou K; Johnson N
Am J Surg; 2006 Oct; 192(4):496-8. PubMed ID: 16978958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
